Feature Channels:

Parkinson’s Disease

Add to Favorites Subscribe Share
fbshare-Parkinson’s Disease

Showing results

110 of 157
Embargo will expire:
20-Nov-2019 5:00 AM EST
Released to reporters:
15-Nov-2019 1:35 PM EST

EMBARGOED

A reporter's PressPass is required to access this story until the embargo expires on 20-Nov-2019 5:00 AM EST

The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application.
If you have not yet registered, please do so. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

A Game-Changing Test for Prion, Alzheimer’s, and Parkinson’s Diseases is on the Horizon

Lawrence Berkeley National Laboratory

A new test agent can easily and efficiently detect the misfolded protein aggregates that cause devastating neurological diseases in blood samples. The technology could lead to early diagnosis of prion, Alzheimer's, and Parkinson's diseases for the first time.

Channels: All Journal News, Alzheimer's and Dementia, Materials Science, Parkinson’s Disease, PLOS ONE, DOE Science News,

Released:
6-Nov-2019 11:00 AM EST
Research Results

Name that tune: Brain takes just 100 to 300 milliseconds to recognize familiar music

University College London

The human brain can recognise a familiar song within 100 to 300 milliseconds, highlighting the deep hold favourite tunes have on our memory, a UCL study finds.

Channels: Aging, All Journal News, Alzheimer's and Dementia, Neuro, Parkinson’s Disease, Scientific Reports,

Released:
30-Oct-2019 1:05 PM EDT
Research Results
Newswise: Machine Learning Leads to Novel Way to Track Tremor Severity in Parkinson’s Patients

Machine Learning Leads to Novel Way to Track Tremor Severity in Parkinson’s Patients

Florida Atlantic University

Physical exams only provide a snapshot of a Parkinson’s patient’s daily tremor experience. Scientists have developed algorithms that, combined with wearable sensors, can continuously monitor patients and estimate total Parkinsonian tremor as they perform a variety of free body movements in their natural settings. This new method holds great potential for providing a full spectrum of patients’ tremors and medication response, providing clinicians with key information to effectively manage and treat their patients with this disorder.

Channels: Artificial Intelligence, Healthcare, Neuro, Parkinson’s Disease, Technology, All Journal News,

Released:
30-Oct-2019 9:00 AM EDT
Research Results
Newswise: Henry Ford Health System, Montfort Launch Pilot Study for Patients with Parkinson's Disease

Henry Ford Health System, Montfort Launch Pilot Study for Patients with Parkinson's Disease

Henry Ford Health System

Henry Ford Health System and Montfort (Mon4t), an Israeli startup specializing in neurological disorders, have launched a pilot study related to artificial intelligence (AI) and Parkinson’s disease. In 2018, Mon4t was the winner of Henry Ford Innovations’ first AI challenge. The multi-disciplinary team responsible for leveraging Henry Ford Health System’s intellectual property, Henry Ford Innovations’ AI challenge was part of its Global Technology Development Program in Israel.

Channels: Artificial Intelligence, Neuro, Parkinson’s Disease,

Released:
24-Oct-2019 1:05 PM EDT
Research Results
Newswise: Novel Agent Flips on 'Garbage Disposal' in Neurons, Eliminating Toxic Brain Proteins in Mice
  • Embargo expired:
    22-Oct-2019 2:00 PM EDT

Novel Agent Flips on 'Garbage Disposal' in Neurons, Eliminating Toxic Brain Proteins in Mice

Georgetown University Medical Center

Neuroscientists at Georgetown University Medical Center say they have developed and tested an agent that reduces the buildup of toxic proteins in animal models of both Parkinson’s and Alzheimer’s diseases, and improves cognitive and motor behavior.

Channels: Alzheimer's and Dementia, Neuro, Parkinson’s Disease, All Journal News,

Released:
18-Oct-2019 2:05 PM EDT
Feature
Newswise: Exposure to Environmental PCBs Impairs Brain Function In Mice
  • Embargo expired:
    22-Oct-2019 8:00 AM EDT

Exposure to Environmental PCBs Impairs Brain Function In Mice

Georgetown University Medical Center

Human-made toxic chemicals that linger indefinitely in the environment disrupt the performance of critical helper cells in the mouse brain, leading to impaired function over long-term exposures.

Channels: Cancer, Cell Biology, Neuro, Parkinson’s Disease, All Journal News, Environmental Health, Environmental Science,

Released:
18-Oct-2019 1:50 PM EDT
Research Results
Newswise: Study Reveals How Collapse of Protein Processes is Driver of Aging and Death

Study Reveals How Collapse of Protein Processes is Driver of Aging and Death

Stony Brook Medicine

A new Stony Brook University-led study, to be published in PNAS, provides a biophysical model that reveals how damage accumulates in proteins with age and is a trigger to death. The finding opens a door to a better understanding of the molecular origins of age-related neurodegenerative diseases.

Channels: Aging, All Journal News, Alzheimer's and Dementia, Cell Biology, Neuro, Parkinson’s Disease, PNAS, Grant Funded News,

Released:
16-Oct-2019 5:05 AM EDT
Research Results
PennMed_logo.png
Released:
10-Oct-2019 1:20 PM EDT
Research Results

Georgetown Offers Multiple Clinical Trials for People with Lewy Body Dementia

Georgetown Lombardi Comprehensive Cancer Center

Georgetown University Medical Center, a Lewy Body Dementia (LBD) Association Research Center of Excellence, is now offering three clinical trials to study new treatments for LBD, a disease often confused with Parkinson’s and Alzheimer’s disease.

Channels: Alzheimer's and Dementia, Neuro, Parkinson’s Disease, National Institutes of Health (NIH), Clinical Trials,

Released:
8-Oct-2019 7:05 AM EDT
Announcement

Showing results

110 of 157

Chat now!
5.92717